Torrid Holdings Inc. CURV reported better-than-expected third-quarter financial results and issued FY23 revenue guidance above estimates on Thursday.
Net sales fell 8.3% Y/Y to $275.4 million, beating the consensus of $245.8 million. EPS loss of $(0.03) came above the consensus of $(0.05), according to data from Benzinga Pro.
For FY23, Torrid raised guidance for net sales to $1.125 billion-$1.140 billion (from $1.080 billion and $1.115 billion) vs. $1.09 billion estimate and adjusted EBITDA to $99 million-$103 million (from $90 million-$100 million).
Torrid shares jumped 20.7% to trade at $5.01 on Friday.
These analysts made changes to their price targets on Torrid following earnings announcement.
- Morgan Stanley raised the price target on Torrid from $2 to $4. Morgan Stanley analyst Alex Straton maintained an Equal-Weight rating.
- Telsey Advisory Group increased the price target on Torrid from $2 to $5. Telsey Advisory Group analyst Dana Telsey maintained a Market Perform rating.
Check This Out: Insiders Buying Bristol-Myers Squibb And 3 Other Stocks
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.